ALBO
Closed
Albireo Pharma Inc
44.15
0.00 (0.00%)
Last Update: 03 Mar 2023 00:00:00
Yesterday: 44.15
Day's Range: 0. - 0.
Send
sign up or login to leave a comment!
When Written:
44.15
Albireo Pharma Inc is a biopharmaceutical company that focuses on developing and commercializing therapies for rare pediatric liver diseases and other liver-related disorders. The company's lead product candidate, odevixibat, is an oral medication designed to treat progressive familial intrahepatic cholestasis (PFIC), a rare genetic disorder that affects the liver. Albireo Pharma also has other pipeline candidates in development, including A3907, a treatment for nonalcoholic steatohepatitis (NASH). The company was founded in 2008 and is headquartered in Boston, Massachusetts. It is publicly traded on the NASDAQ under the ticker symbol ALBO.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








